GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Rekvina Laboratories Ltd

Rekvina Labs: Independent Directors Recommend Open Offer at Rs. 10 per share

M&A ● No Immediate Change LOW RISK
📅 Filed on BSE: 25 Jun 2026, 02:28 PM IST  ·  BSE ID: f4c1e9a0-666a-46fd-896f-8e7109cadfff
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's independent directors advise shareholders to consider selling their shares in the open offer at Rs. 10 each.
🤖 AI Summary
  • Rekvina Laboratories Ltd's Committee of Independent Directors (IDC) recommended the open offer.
  • IDC advises shareholders to consider the open offer price of Rs. 10 per equity share.
  • The open offer is for 28,90,100 equity shares, representing 26% of the company's paid-up capital.
  • Recommendation is based on the IDC's assessment of relevant factors and the offer document.
  • Shareholders are advised to make their own informed decisions regarding the open offer.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Open Offer Price
Rs. 10 per equity share
Shares offered
28,90,100 equity shares
Percentage of Paid-up Share Capital
26%
🏢 How This Affects the Company
⚠️
Risk Impact
This filing confirms the IDC has reviewed the open offer, reducing uncertainty regarding their stance.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must decide whether to tender their shares in the open offer, considering the IDC's recommendation and other factors.
👤
Who Is Affected
All public shareholders of Rekvina Laboratories Ltd are affected, as the offer pertains to up to 26% of the company's equity shares.
🔍
Management Signal
The Independent Directors have fulfilled their regulatory obligation to provide an unbiased recommendation to shareholders regarding the open offer.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Open offer tendering period — monitor shareholder participation rates.
Announcement of open offer results — confirm number of shares tendered.
Change in shareholding pattern post-open offer — observe new promoter holdings.
LOW RISK The filing is a procedural update for an existing open offer, not introducing new risks.
💡 Investor Takeaway
Rekvina Laboratories Ltd's Independent Directors have formally recommended the ongoing open offer. They advise shareholders to consider the offer price of Rs. 10 per equity share for 28,90,100 shares, representing 26% of the paid-up capital.
⚖️ Strengths & Concerns

✅ Positives

  • The Committee of Independent Directors has provided its formal recommendation, offering guidance to shareholders.
  • The recommendation clarifies the IDC's position on the open offer terms, specifically the Rs. 10 per share price.
📅 Company Track Record
Rekvina Laboratories Ltd has had multiple updates regarding this mandatory open offer, with initial intimation in April 2026 for 28,90,100 shares at Rs. 10 each, and an open offer period set for July 1, 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is the recommendation from Rekvina Labs' Independent Directors regarding the open offer?
Rekvina Laboratories Ltd's Committee of Independent Directors has recommended that shareholders consider the open offer price of Rs. 10 per equity share.
How many shares are involved in the Rekvina Labs open offer?
The open offer is for 28,90,100 equity shares of Rekvina Laboratories Ltd, representing 26% of the total paid-up share capital.
What is the offer price for the Rekvina Labs open offer?
The open offer price for Rekvina Laboratories Ltd equity shares is Rs. 10 per share.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.